Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The OpenAI Startup Fund is a corporate venture capital initiative established in 2021 and based in San Francisco. It invests in early-stage (seed to Series B) AI startups across various sectors, including healthcare, law, education, and infrastructure, with typical checks ranging from $500K to $1M. Operating independently of OpenAI's direct capital, it is backed by external investors like Microsoft. The fund provides portfolio companies with access to OpenAI technology, Azure credits, and community support. Ian Hathaway leads the fund, which has notably invested in companies such as Ambience Healthcare, Chai Discovery, and Figure AI.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OpenAI Startup Fund.